SCHEMBL2902352

SCHEMBL2902352

CN1CCC(N(C)Cc2cn(-c3ccc(-c4ccc(F)cc4)cc3)nc2-c2ccco2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
KDM4E B2RXH2 6/20 0.45
MAPT P10636 5/20 0.41
NPC1 O15118 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 1/20 0.39
SLC2A1 P11166 1/20 0.39
AGTR1 P30556 1/20 0.39
NPSR1 Q6W5P4 5/20 0.37
MAPK1 P28482 3/20 0.37
LMNA P02545 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTT P42858 3/20 0.37
MAP4K4 O95819 1/20 0.36
POLB P06746 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
XBP1 P17861 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904628 0.90 KDM4E (0.51) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL2902342 0.89 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL2904846 0.87 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL5224732 0.81 MAP4K4 (0.34) ALDH1A1KDM4EMAPTMAP4K4SMN1; SMN2
SCHEMBL2904847 0.79 ALDH1A1 (0.33) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2901798 0.78 MAPT (0.50) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL2902617 0.77 KDM4E (0.46) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL2904861 0.75 POLB (0.55) ALDH1A1KDM4EMEN1KMT2AAGTR1
SCHEMBL2909330 0.75 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTNPC1MEN1
SCHEMBL2907733 0.75 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611107-B1 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS MERCK PATENT GMBH (DE) 2010-08-18 EP claimed